source
- Experts warn FDA against approving Grail’s ineffective multicancer blood testPhysician and cancer‑screening researcher H. Gilbert Welch argues that the FDA should not greenlight Grail’s multicancer blood test, noting the company’s trial of 140,000 participants used a weak s…
- Doctor warns AI-driven documentation may boost hospital bills without improving careA resident physician writes that recent Blue Cross Blue Shield research has sparked anger by suggesting hospitals use AI tools to increase charges without adding care. The study claims hospitals e…